| Range | 6M |
|---|---|
| First date | — |
| Last date | — |
| Open | — |
| High | — |
| Low | — |
| Close | — |
| Volume | — |
| Plotted bars | 0 |
Event records
Event records load after the price chart.
Healthcare · Medical Devices
The Quantellect read. SNN fell 0.62% in the Nov 18 session to $30.32. The borrow fee is 4.32%. Four active firms cover the stock as of Nov 19, 2026; one active firm with a target averages $30.00 over 12 months. Descriptive summary of the data on this page, not a recommendation.
—
RSI (14) 59.8 (overbought above 70, oversold below 30)
—
FINRA settlement Oct 30, 2026
Price $30.32 · As of Nov 18, 2026, 3:59 PM ET
| Range | 6M |
|---|---|
| First date | — |
| Last date | — |
| Open | — |
| High | — |
| Low | — |
| Close | — |
| Volume | — |
| Plotted bars | 0 |
Event records load after the price chart.
| Range | 6M |
|---|---|
| First close | — |
| Last close | — |
| High | — |
| Low | — |
| Volume | — |
SNN · nyse · USD
Last completed session: Nov 18, 2026
Split-adjusted · volume in shares
— · Notable price movement not available
— · Options flow not available
— · Industry comparison not available
Neutral
Based on 4 active firms as of Nov 19, 2026 (365-day activity window)
As of Nov 19, 2026 across 1 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast →In the last 60 days: 0 insider sales and 0 purchases. No congressional trades in 90 days.
GlobeNewswire · Press release
ACCESS Newswire · Press release
GlobeNewswire · Press release
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization
Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.